Global /India /Healthcare /Drug Manufacturers - General /AMBALALSA

Ambalal Sarabhai Enterprises Ltd.

AMBALALSA

• NSE: AMBALALSA • Delayed

32.65INR -1.7%

0.3458 USD

As of 20 June 2026, Ambalal Sarabhai Enterprises Ltd. has a market cap of $25.82M USD, ranking #35307 globally and #2444 in India. It ranks #3194 in the Healthcare sector, and #1078 in the Drug Manufacturers - General industry.

Global Rank

35307

Country Rank

2444

Sector Rank

3194

Industry Rank

1078

Key Stats

Market Cap

$25.82MUSD

2.44B INR

Enterprise Value

$29.35MUSD

2.77B INR

Revenue (TTM)

$21.48MUSD

2.03B INR

EBITDA (TTM)

$2.34MUSD

221.03M INR

Net Income (TTM)

$1.11MUSD

104.58M INR

EBITDA Margin

11%

Profit Margin

5.2%

PE Ratio

23.3

PS Ratio

1.2

PB Ratio

1.7

EV/EBITDA

12.1

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Mohal Sarabhai open_in_new

Employees

547

Founded

1977

Website

ase.life open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.7%	3.9%	-0.2%	-1.1%	-1.1%	-1.1%	-1.1%	-1.1%	-1.1%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	AMBALALSA Ambalal Sarabhai Enterprises Ltd ISIN: INE432A01017 Shares Out.: Shares Outstanding: 76.633M¹ Shares Float: 56.891M² TV: TradingView: NSE: AMBALALSA SA: Stock Analysis: NSE: AMBALALSA YF: Yahoo Finance: AMBALALSA.NS GF: Google Finance: NSE: AMBALALSA BA: Barron's: AMBALALSA MS: Morningstar: XNSE: AMBALALSA	32.65 INR	TV: TradingView: NSE: AMBALALSA SA: Stock Analysis: NSE: AMBALALSA YF: Yahoo Finance: AMBALALSA.NS GF: Google Finance: NSE: AMBALALSA BA: Barron's: AMBALALSA MS: Morningstar: XNSE: AMBALALSA
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	500009 (AMBALALSA) Ambalal Sarabhai Enterprises Ltd ISIN: INE432A01017 TV: TradingView: BSE: AMBALALSA SA: Stock Analysis: BOM: 500009 YF: Yahoo Finance: 500009.BO GF: Google Finance: BOM: 500009 BA: Barron's: 500009 MS: Morningstar: XBOM: 500009	32.31 INR	TV: TradingView: BSE: AMBALALSA SA: Stock Analysis: BOM: 500009 YF: Yahoo Finance: 500009.BO GF: Google Finance: BOM: 500009 BA: Barron's: 500009 MS: Morningstar: XBOM: 500009

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Ambalal Sarabhai Enterprises Ltd.

Ambalal Sarabhai Enterprises Limited, together with its subsidiaries, manufactures, markets, and supplies pharmaceutical products in India and internationally. The company offers products for oncology, infertility, and uro-gynaec areas; generic and veterinary products; antifungal active ingredient products; vitamin C coated products; and analytical, test, and measuring instruments, as well as supplies finished dosage forms and active pharmaceutical ingredients. It also provides broadcast and professional video/audio, and electronic products. Ambalal Sarabhai Enterprises Limited was incorporated in 1977 and is based in Ahmedabad, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.22B 4.27T INR 175K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.38B 1.73T INR 71K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.17B 1.43T INR 59K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.73B 1.11T INR 45K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.87B 931.67B INR 38K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.71B 916.53B INR 38K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 3M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 2M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 1M%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 1M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 1M%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 1M%	15.1	United States

chevron_leftBack